On September 25th, join Contract Pharma and Dr. Soodeh Baghaee-Ravari, Director of Process Development at Genezen, to discover how Roche’s EndoCleave endonuclease enables scalable, cost-effective DNA clearance in AAV and LVV manufacturing—ensuring purity, safety, and process reliability.
On October 2, our expert panel, featuring representatives from Bausch+Stroebel, SKAN, and Grand River Aseptic Manufacturing, will discuss how sterile filling equipment adapts to variations in drug delivery systems while maintaining compliance with regulatory requirements.
On October 7, Contract Pharma and experts from Douglas CDMO will explore the critical role of bioavailability in a drug's success and how softgel technology can be a strategic solution for commercial longevity.
nanoComposix, LLC (A Fortis Life Sciences® company) headquartered in San Diego, CA provides precisely engineered and highly characterized nanomaterials to a global customer base. nanoComposix is an ISO 13485:2016 certified, FDA-registered developer and contract manufacturer.
UI Pharmaceuticals, an FDA-registered, university-affiliated pharmaceutical manufacturing facility, has been a trusted partner since 1974. We provide comprehensive development, manufacturing, and testing services for sterile solutions, lyophilized products, tablets, capsules, and other forms, ensuring quality, compliance, and client satisfaction.
